Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
基本信息
- 批准号:6748429
- 负责人:
- 金额:$ 37.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-20 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:adipocytesaminoacid metabolismantibodybiological signal transductioncarbohydrate metabolismchemical kineticsenzyme activityenzyme inhibitorshormone regulation /control mechanismimmunoprecipitationinsulinlaboratory rabbitlaboratory ratleucinemitochondriaphosphorylationprotein kinaseprotein sequencerecombinant proteins
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of these studies is to understand the regulation of leucine metabolism in the context of leucine's role as a direct acting nutrient signal. Rises in plasma leucine concentration after a protein-containing meal stimulate protein synthesis and cell signaling pathways used by insulin such as the mammalian Target of Rapamycin (mTOR) pathway. The mTOR signaling pathway is important for cell cycle progression, hypertrophic growth and a number of key adipose tissue functions. Therefore, it is important to understand how the leucine signal is terminated and how that termination is regulated. The proposed studies will focus on the major rate-limiting step in leucine metabolism catalyzed by the branched-chain alpha-keto acid dehydrogenase (BCKD), which is regulated by a specific intramitochondrial kinase and phosphatase. Two fundamental questions drive the proposed studies. 1) Is activation of BCKD by the alpha-keto acid of leucine (KIC) a step in the activation of mTOR by leucine? 2) How does insulin, an extracellularly regulated receptor, stimulate the activity of a mitochondrial matrix enzyme, BCKD? In the four specific aims we will address these questions. First a rapid simple test system to measure acute regulation (activity state) of BCKD based on a new antibody that specifically recognizes phosphorylated BCKD (inactive, pS293) will be developed. Second, three approaches will be used to determine the role of BCKD activation in leucine regulation of mTOR: time course, structure-activity and molecular approaches will be used. Third, the mechanism whereby insulin regulates BCKD will be investigated. The cytosolic signaling pathway required for insulin regulation of BCKD will be determined. The potential role of the BCKD kinase and metabolites known to be affected by insulin action will also be investigated. Finally, the hypothesis that insulin activation of BCKD results from activation of BCKD phosphatase will be tested. Subunits of BCKD phosphatase will be cloned and sequenced in order to prepared antibodies and over express recombinant protein. The antibodies will be used to examine the potential effects of insulin on BCKD phosphatase and its inhibitor protein. The recombinant phosphatase will be used to test potential mechanisms of insulin action and for physical and kinetic characterization. The results from this study will provide insight into mechanisms involved in integration of carbohydrate and protein metabolism.
描述(由申请人提供):这些研究的长期目标是在亮氨酸作为直接作用的营养信号的背景下了解亮氨酸代谢的调节。进食蛋白质后,血浆亮氨酸浓度升高会刺激蛋白质合成和胰岛素使用的细胞信号通路,如哺乳动物雷帕霉素靶蛋白(mTOR)通路。mTOR信号通路对细胞周期进程、肥厚生长和一些关键的脂肪组织功能至关重要。因此,了解亮氨酸信号是如何终止的以及这种终止是如何调节的是很重要的。建议的研究将集中在由支链α -酮酸脱氢酶(BCKD)催化的亮氨酸代谢的主要限速步骤,该酶由特定的线粒体内激酶和磷酸酶调节。两个基本问题推动了拟议的研究。1)亮氨酸α -酮酸(KIC)激活BCKD是亮氨酸激活mTOR的一个步骤吗?2)细胞外调节受体胰岛素如何刺激线粒体基质酶BCKD的活性?我们将在四个具体目标中处理这些问题。首先,将开发一种基于特异性识别磷酸化BCKD(失活的pS293)的新抗体的快速简单测试系统来测量BCKD的急性调节(活性状态)。其次,将使用三种方法来确定BCKD激活在亮氨酸调节mTOR中的作用:时间过程,结构-活性和分子方法。第三,胰岛素调节BCKD的机制将被研究。胰岛素调节BCKD所需的胞质信号通路将被确定。BCKD激酶和已知受胰岛素作用影响的代谢物的潜在作用也将被研究。最后,我们将验证胰岛素激活BCKD是由BCKD磷酸酶激活引起的假说。BCKD磷酸酶亚基将被克隆和测序,以制备抗体和过表达重组蛋白。这些抗体将用于检测胰岛素对BCKD磷酸酶及其抑制蛋白的潜在影响。重组磷酸酶将用于测试胰岛素作用的潜在机制以及物理和动力学表征。这项研究的结果将为碳水化合物和蛋白质代谢整合的机制提供深入的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER JOHN LYNCH其他文献
CHRISTOPHER JOHN LYNCH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER JOHN LYNCH', 18)}}的其他基金
Adipose Organ Transplant for Treatment of Maple Syrup Urine Disease
脂肪器官移植治疗枫糖浆尿病
- 批准号:
8281453 - 财政年份:2011
- 资助金额:
$ 37.43万 - 项目类别:
Adipose Organ Transplant for Treatment of Maple Syrup Urine Disease
脂肪器官移植治疗枫糖浆尿病
- 批准号:
8091967 - 财政年份:2011
- 资助金额:
$ 37.43万 - 项目类别:
Mechanisms of drug side effects related to obesity and diabetes
肥胖和糖尿病相关药物副作用的机制
- 批准号:
8034612 - 财政年份:2010
- 资助金额:
$ 37.43万 - 项目类别:
Mechanisms of drug side effects related to obesity and diabetes
肥胖和糖尿病相关药物副作用的机制
- 批准号:
8146903 - 财政年份:2010
- 资助金额:
$ 37.43万 - 项目类别:
Mechanisms of drug side effects related to obesity and diabetes
肥胖和糖尿病相关药物副作用的机制
- 批准号:
8474748 - 财政年份:2010
- 资助金额:
$ 37.43万 - 项目类别:
Mechanisms of drug side effects related to obesity and diabetes
肥胖和糖尿病相关药物副作用的机制
- 批准号:
8288238 - 财政年份:2010
- 资助金额:
$ 37.43万 - 项目类别:
Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
- 批准号:
7677993 - 财政年份:2003
- 资助金额:
$ 37.43万 - 项目类别:
Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
- 批准号:
6874307 - 财政年份:2003
- 资助金额:
$ 37.43万 - 项目类别:
Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
- 批准号:
7387603 - 财政年份:2003
- 资助金额:
$ 37.43万 - 项目类别:
Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
- 批准号:
7920817 - 财政年份:2003
- 资助金额:
$ 37.43万 - 项目类别:














{{item.name}}会员




